{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:52:33Z","timestamp":1791049953996,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"DOI":"10.1007\/s43441-026-01053-4","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:01:46Z","timestamp":1791046906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Common Deficiencies in Dossiers of Finished Pharmaceutical Products Submitted for Registration and Related Factors: A Mixed-Method Study in Tanzania"],"prefix":"10.1007","author":[{"given":"Francis","family":"Kittinga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Maganda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eulambius","family":"Mlugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Mwita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"issue":"6","key":"1053_CR1","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.5958\/0974-360X.2020.00525.9","volume":"13","author":"C Karthika","year":"2020","unstructured":"Karthika C, Sureshkumar R. A forecast on strategies for regulatory requirement of drug product registration in African pharmaceutical. Res J Pharm Technol. 2020;13(6):2966\u201370.","journal-title":"Res J Pharm Technol"},{"key":"1053_CR2","unstructured":"Mahaparale S, Desai B. Role and overview of drug regulatory affairs in pharmaceutical industry with implementation of CTD and ECTD. Sonali al World J Pharm Res. 2018;7."},{"issue":"2","key":"1053_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.22270\/ijdra.v7i2.318","volume":"7","author":"S Godiyal","year":"2019","unstructured":"Godiyal S. Regulatory requirements for preparation of Dossier for registration of Pharmaceutical products in ACTD & CTD format. Int J Drug Regul Affairs (IJDRA). 2019;7(2):51\u201361.","journal-title":"Int J Drug Regul Affairs (IJDRA)"},{"issue":"12","key":"1053_CR4","first-page":"1","volume":"1","author":"M Rupnawar","year":"2024","unstructured":"Rupnawar M, Wani P. Pharmaceutical regulatory affairs: an overview of global regulatory frameworks and emerging trends. Int J Sci Res Technol. 2024;1(12):1\u201311.","journal-title":"Int J Sci Res Technol"},{"issue":"1","key":"1053_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.22270\/ijdra.v10i1.510","volume":"10","author":"JK Badjatya","year":"2022","unstructured":"Badjatya JK, Jangid A, Dodiya P, Soni S, Parekh A, Patel D, Patel J. Comparative study of regulatory requirements of drug product in emerging market. Int J Drug Regul Affairs. 2022;10(1):51\u201382.","journal-title":"Int J Drug Regul Affairs"},{"issue":"1","key":"1053_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40545-021-00398-5","volume":"15","author":"L Moeti","year":"2022","unstructured":"Moeti L, Litedu M, Joubert J. Common deficiencies found in generic finished pharmaceutical product (FPP) applications submitted for registration to the South African health products regulatory authority (SAHPRA). J Pharm Policy Pract. 2022;15(1):6.","journal-title":"J Pharm Policy Pract"},{"issue":"2","key":"1053_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/1741134312448062","volume":"9","author":"WZ Worku","year":"2012","unstructured":"Worku WZ, Gordon J, Stahl MM, R\u00e4go L. Deficiencies in generic product dossiers as submitted to the WHO prequalification of medicines programme. J Generic Med. 2012;9(2):63\u201374.","journal-title":"J Generic Med"},{"key":"1053_CR8","doi-asserted-by":"publisher","first-page":"1472495","DOI":"10.3389\/fmed.2024.1472495","volume":"11","author":"HK Hassen","year":"2024","unstructured":"Hassen HK, Mekasha YT, Tegegne AA, Ozalp Y. A narrative review on problems in product quality, regulatory system constraints, and the concept of quality by design as a solution for quality assurance of African medicines. Front Med. 2024;11:1472495.","journal-title":"Front Med"},{"issue":"10","key":"1053_CR9","doi-asserted-by":"publisher","first-page":"e0003241","DOI":"10.1371\/journal.pgph.0003241","volume":"4","author":"AM Fimbo","year":"2024","unstructured":"Fimbo AM, Sillo HB, Nkayamba A, Kisoma S, Mwalwisi YH, Idris R, Asiimwe S, Githendu P, Ogbuoji O, Morrison L, Bump JB. Strengthening regulation for medical products in Tanzania: an assessment of regulatory capacity development, 1978\u20132020. PLOS Global Public Health. 2024;4(10):e0003241.","journal-title":"PLOS Global Public Health"},{"key":"1053_CR10","volume-title":"Statistics: an introductory analysis","author":"T Yamane","year":"1973","unstructured":"Yamane T. Statistics: an introductory analysis. London: John Weather Hill, Inc.; 1973."},{"key":"1053_CR11","unstructured":"Tanzania Medicines and Medical Devices Authority (TMDA). Medicines registration guidelines. 2022. https:\/\/www.tmda.go.tz\/publications\/42"},{"key":"1053_CR12","doi-asserted-by":"crossref","unstructured":"Benetti C, Benetti AA. Quality by design in formulation development. In: Introduction to quality by design (QbD) from theory to practice. Singapore: Springer Nature Singapore; 2024. pp. 139\u201359","DOI":"10.1007\/978-981-99-8034-5_6"},{"issue":"12","key":"1053_CR13","first-page":"1","volume":"8","author":"M Kabir","year":"2024","unstructured":"Kabir M, Rana MR, Debnath A. The role of quality assurance in accelerating pharmaceutical research and development: strategies for ensuring regulatory compliance and product integrity. J Angiother. 2024;8(12):1\u20131.","journal-title":"J Angiother"},{"issue":"11","key":"1053_CR14","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.3390\/pharmaceutics14112324","volume":"14","author":"O Gonz\u00e1lez-Gonz\u00e1lez","year":"2022","unstructured":"Gonz\u00e1lez-Gonz\u00e1lez O, Ramirez IO, Ramirez BI, O\u2019Connell P, Ballesteros MP, Torrado JJ, Serrano DR. Drug stability: ICH versus accelerated predictive stability studies. Pharmaceutics. 2022;14(11):2324.","journal-title":"Pharmaceutics"},{"issue":"5","key":"1053_CR15","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.4269\/ajtmh.20-0255","volume":"103","author":"N Hagen","year":"2020","unstructured":"Hagen N, Bizimana T, Kayumba PC, Khuluza F, Heide L. Stability of oxytocin preparations in Malawi and Rwanda: stabilizing effect of chlorobutanol. Am J Trop Med Hyg. 2020;103(5):2129.","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"1053_CR16","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s43441-019-00021-5","volume":"54","author":"G Ball","year":"2020","unstructured":"Ball G, Reblin T, Buchanan J, Hendrickson BA, Lewis E, Schnell PM, Rockhold FW. A framework for safety evaluation throughout the product development life-cycle. Therapeutic Innov Regul Sci. 2020;54(4):821\u201330.","journal-title":"Therapeutic Innov Regul Sci"},{"issue":"3","key":"1053_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/2230-973X.187350","volume":"6","author":"K Pramod","year":"2016","unstructured":"Pramod K, Tahir MA, Charoo NA, Ansari SH, Ali J. Pharmaceutical product development: A quality by design approach. Int J Pharm Invest. 2016;6(3):129.","journal-title":"Int J Pharm Invest"},{"issue":"1","key":"1053_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1208\/s12248-022-00685-2","volume":"24","author":"T Verch","year":"2022","unstructured":"Verch T, Campa C, Chery CC, Frenkel R, Graul T, Jaya N, Nakhle B, Springall J, Starkey J, Wypych J, Ranheim T. Analytical quality by design, life cycle management, and method control: analytical quality by design, life cycle management, and method control. AAPS J. 2022;24(1):34.","journal-title":"AAPS J"},{"key":"1053_CR19","doi-asserted-by":"publisher","DOI":"10.5731\/pdajpst.2017.007658","author":"FL Degrazio","year":"2017","unstructured":"Degrazio FL. Holistic considerations in optimizing a sterile product package to ensure container closure integrity. PDA J Pharm Sci Technol. 2017. https:\/\/doi.org\/10.5731\/pdajpst.2017.007658","journal-title":"PDA J Pharm Sci Technol"},{"key":"1053_CR20","doi-asserted-by":"crossref","unstructured":"Akers MJ. Sterile drug products: formulation, packaging, manufacturing and quality. CRC; 2016. p. 19.","DOI":"10.3109\/9781420020564"},{"issue":"4","key":"1053_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.22270\/ijdra.v7i4.371","volume":"7","author":"PV Chaudhari","year":"2019","unstructured":"Chaudhari PV, Badjatya JK. Good practices in management of deficiencies in CTD dossier and comparative study for US, EU and Australia. Int J Drug Regul Affairs. 2019;7(4):40\u201355.","journal-title":"Int J Drug Regul Affairs"},{"issue":"1","key":"1053_CR22","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1002\/puh2.158","volume":"3","author":"P Chejor","year":"2024","unstructured":"Chejor P, Dorji T, Dema N, Stafford A. Good manufacturing practice in low-and middle\u2010income countries: challenges and solutions for compliance. Public Health Challenges. 2024;3(1):e158.","journal-title":"Public Health Challenges"},{"issue":"5","key":"1053_CR23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4103\/ijp.ijp_297_23","volume":"56","author":"R Pathak","year":"2024","unstructured":"Pathak R, Singal R, Mitra S, Koul S, Sharma S. Unlocking the benefits of drug master file filing in the Indian pharmaceutical industries. Indian J Pharmacol. 2024;56(5):342\u20137.","journal-title":"Indian J Pharmacol"}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01053-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-026-01053-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01053-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:01:47Z","timestamp":1791046907000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43441-026-01053-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":23,"alternative-id":["1053"],"URL":"https:\/\/doi.org\/10.1007\/s43441-026-01053-4","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,3]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}